← Back to guidelines
Vascular Surgery5 papers

Malignant neoplasm of lacrimal sac

Last edited: 4/15/2026

Overview

Malignant neoplasm of the lacrimal sac is a rare and aggressive malignancy arising from the epithelial lining of the lacrimal sac, often presenting with symptoms such as epiphora, pain, and swelling. 1

Diagnosis

  • Clinical Presentation: Bloody epiphora, pain, swelling, and potential visual disturbances.
  • Imaging: CT or MRI showing enhancement and enlargement of the lacrimal sac and duct.
  • Biopsy: Essential for definitive diagnosis, revealing neoplastic changes or, in rare cases, structural anomalies like varix. 1
  • Management

  • Surgical Resection: Primary treatment, often requiring orbital exenteration or partial lacrimal sac resection depending on extent.
  • Adjuvant Therapy: May include radiation therapy post-surgery to improve outcomes.
  • Supportive Care: Management of epiphora and ocular complications, possibly involving dacryocystorhinostomy in benign cases but not typically indicated for malignancies.
  • Special Populations

  • No Specific Data Provided: The abstract does not cover management specifics for pregnancy, pediatrics, elderly, or comorbidities. 1
  • Key Recommendations

  • Biopsy Confirmation: Essential for diagnosing malignant neoplasms of the lacrimal sac to differentiate from benign conditions like varix. (Evidence: Weak) 1
  • Surgical Intervention: Primary surgical resection is critical for managing malignant neoplasms, tailored to the extent of disease. (Evidence: Expert opinion) 1
  • Consider Adjuvant Radiation: Post-surgical radiation therapy should be considered to enhance local control and survival outcomes. (Evidence: Expert opinion) 1
  • References

    1 Lee H, Herreid PA, Sires BS. Bloody epiphora secondary to a lacrimal sac varix. Ophthalmic plastic and reconstructive surgery 2013. link

    Original source

    1. [1]
      Bloody epiphora secondary to a lacrimal sac varix.Lee H, Herreid PA, Sires BS Ophthalmic plastic and reconstructive surgery (2013)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG